DANIEL LEE: Open Payments
NPI 1003396904 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$214 in 9 payments from 6 companies in 2025. Trend: 2023 $28 · 2024 $295 · 2025 $214
Food & beverage: $214
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $104 |
| Corium, LLC | 1 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Lilly USA, LLC | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: GATTEX, Azstarys, JARDIANCE, AIRSUPRA, MOUNJARO, TRELEGY ELLIPTA.
Industry payments across OK — which companies pay providers there.
